Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carroll, J. E.
Right arrow Articles by Hagberg, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carroll, J. E.
Right arrow Articles by Hagberg, J. M.
NEUROLOGY 1980;30:618
© 1980 American Academy of Neurology

Carnitine "deficiency"

Lack of response to carnitine therapy

James E. Carroll, M.D., Michael H. Brooke, M.D., Darryl C. DeVivo, M.D., Jack B. Shumate, M.D., Rüdiger Kratz, M.D., Steven P. Ringel, M.D. and James M. Hagberg, Ph.D.

Departments of Neurology and Neurosurgery (Neurology) and Pediatrics (Drs. Carroll and DeVivo), the Department of Neurology and Neurosurgery (Drs. Brooke, Shumate, and Kratz), and the Department of Preventive Medicine (Dr. Hagberg), Washington University School of Medicine, St. Louis, MO, and the Department of Neurology (Dr. Ringel), University of Colorado Medical Center, Denver, CO.

A 29-year-old woman had muscle weakness, low concentrations of carnitine in muscle and serum, and abnormally low urinary excretion of carnitine. During a fast, exercise capacity declined, ketone body concentrations rose, metabolic acidosis worsened, and she became hypoglycemic. After treatment with oral carnitine, serum carnitine content returned to normal and blood glucose was maintained during fasting, but ketone body concentrations in blood were even higher. Muscle carnitine content and exercise capacity did not improve. This patient demonstrated features of both systemic and muscle carnitine deficiency, suggesting that the current classification of carnitine-deficiency syndromes is inadequate.

Address correspondence and reprint requests to Dr. Carroll, Department of Neurology, Washington University School of Medicine, 660 S. Euclid, Box 8111, St. Louis, MO 63110.

Presented at the thirty-first annual meeting of the American Academy of Neurology, Chicago, April 1979.

This study was supported by a center grant from the Muscular Dystrophy Association and USPHS grant No. RR-00036 from the Division of Research Facilities and Resources. Dr. Carroll is the recipient of an NINCDS Teacher-Investigator Award; Dr. Hagberg is supported by NIH Fellowship No. HL5689.

Accepted for publication September 6, 1979




This article has been cited by other articles:


Home page
J Child NeurolHome page
R. Pons and D. C. De Vivo
Primary and Secondary Carnitine Deficiency Syndromes
J Child Neurol, November 1, 1995; 10(2_suppl): 2S8 - 2S24.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by AAN Enterprises, Inc.